FOXO Technologies Inc. (FOXO)

Market Cap	5.81M
Revenue (ttm)	457,000
Net Income (ttm)	-80.75M
Shares Out	54.98M
EPS (ttm)	-3.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,155,046
Open	0.107
Previous Close	0.108
Day's Range	0.103 - 0.110
52-Week Range	0.092 - 1.800
Beta	1.93
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2023

About FOXO

FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2019
• Employees: 15
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: FOXO

Financial Performance

In 2022, FOXO's revenue was $511,000, an increase of 325.83% compared to the previous year's $120,000. Losses were -$95.26 million, 147.5% more than in 2021.